Expression of cell proliferation markers in pituitary adenomas – correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIα

By Wolfsberger S.   Wunderer J.   Zachenhofer I.   Czech T.   Böcher-Schwarz H.-G.   Hainfellner J.   Knosp E.  

Acta Neurochirurgica, Vol. 146, Iss. 8, 2004-07 ,pp. : 831-839

Springer Publishing Company

Access to resources Recommend Favorite

Central neurocytoma with unusually high MIB-1 index

By Ide M.   Hagiwara S.   Kawamura H.   Aiba M.  

Acta Neurochirurgica, Vol. 148, Iss. 11, 2006-11 ,pp. : 1217-1218

Springer Publishing Company

Access to resources Recommend Favorite

Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas

By Buslei Rolf   Kreutzer Jürgen   Hofmann Bernd   Schmidt Verena   Siebzehnrübl Florian   Hahnen Eric   Eyupoglu Ilker   Fahlbusch Rudolf   Blümcke Ingmar  

Acta Neuropathologica, Vol. 111, Iss. 3, 2006-03 ,pp. : 264-271

Springer Publishing Company

Access to resources Recommend Favorite

Endoscopic transsphenoidal treatment of pituitary adenomas

By Zhang Yazhuo   Wang Zhongcheng   Liu Yejian   Zong Xuyi   Song Ming   Pei Ao   Zhao Peng   Zhang Pengfei   Piao Mingxue  

Neurological Research, Vol. 30, Iss. 6, 2008-07 ,pp. : 581-586

Maney Publishing

Access to resources Recommend Favorite

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB‐1 proliferation index

By  

Neuropathology (Electronic), Vol. 35, Iss. 5, 2015-10 ,pp. : 421-431

John Wiley & Sons Inc

Access to resources Recommend Favorite